These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 35904610

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Screening of potential biomarkers for polycystic ovary syndrome and identification of expression and immune characteristics.
    Liu S, Zhao X, Meng Q, Li B.
    PLoS One; 2023; 18(10):e0293447. PubMed ID: 37883387
    [Abstract] [Full Text] [Related]

  • 6. N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS).
    Zhou S, Hua R, Quan S.
    J Ovarian Res; 2023 Apr 12; 16(1):73. PubMed ID: 37046273
    [Abstract] [Full Text] [Related]

  • 7. Identification and immune features of cuproptosis-related molecular clusters in polycystic ovary syndrome.
    Su Z, Su W, Li C, Ding P, Wang Y.
    Sci Rep; 2023 Jan 18; 13(1):980. PubMed ID: 36653385
    [Abstract] [Full Text] [Related]

  • 8. A novel model based on necroptosis to assess progression for polycystic ovary syndrome and identification of potential therapeutic drugs.
    Wang M, An K, Huang J, Mprah R, Ding H.
    Front Endocrinol (Lausanne); 2023 Jan 18; 14():1193992. PubMed ID: 37745699
    [Abstract] [Full Text] [Related]

  • 9. Cross-talk between oxidative stress and lipid metabolism regulators reveals molecular clusters and immunological characterization in polycystic ovarian syndrome.
    Tan C, Huang S, Xu L, Zhang T, Yuan X, Li Z, Chen M, Chen C, Yan Q.
    Lipids Health Dis; 2024 Aug 15; 23(1):248. PubMed ID: 39143634
    [Abstract] [Full Text] [Related]

  • 10. Identification of MAP1LC3A as a promising mitophagy-related gene in polycystic ovary syndrome.
    Yang Y, Chen X, Liao X, Jiang W, Zhou Y, Sun Y, Zheng B.
    Sci Rep; 2024 Jul 23; 14(1):16982. PubMed ID: 39043888
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Shared diagnostic genes and potential mechanisms between polycystic ovary syndrome and recurrent miscarriage revealed by integrated transcriptomics analysis and machine learning.
    He J, Liu A, Shen H, Jiang Y, Gao M, Yu L, Du W, Zhang X, Fu F.
    Front Endocrinol (Lausanne); 2024 Jul 23; 15():1335106. PubMed ID: 39398336
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification of potential diagnostic genes for atherosclerosis in women with polycystic ovary syndrome.
    Luo Y, Zhou Y, Jiang H, Zhu Q, Lv Q, Zhang X, Gu R, Yan B, Wei L, Zhu Y, Jiang Z.
    Sci Rep; 2024 Aug 06; 14(1):18215. PubMed ID: 39107365
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Placenta inflammation is closely associated with gestational diabetes mellitus.
    Pan X, Jin X, Wang J, Hu Q, Dai B.
    Am J Transl Res; 2021 Aug 06; 13(5):4068-4079. PubMed ID: 34149999
    [Abstract] [Full Text] [Related]

  • 20. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S, Laven JSE, Duhamel A, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1723-1731. PubMed ID: 28854584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.